AHR and early-onset autosomal dominant Alzheimer disease: Interestingly, prototype AhR activators, such as TCDD and BaP, were shown to contribute to the development and progression of age-associated diseases (reviewed in [62, 63]) in different model systems [64] and a recent study showed increased AhR levels in serum brains of Alzheimer’s disease patients [65].